3.8 Article

Reagent-based, modular, tandem Michael approach for obtaining different indoline alkaloid-inspired polycyclic architectures

Journal

JOURNAL OF COMBINATORIAL CHEMISTRY
Volume 10, Issue 3, Pages 405-420

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/cc800036w

Keywords

-

Ask authors/readers for more resources

A modular, reagent-based approach to obtain different indoline alkaloid-in spired, tetracyclic architectures is developed. With the use of TBSOTf as a Lewis acid, we report here a tandem Michael-based approach that led to the synthesis of a diastereomeric mixture of tetracyclic derivatives with two additional six-membered rings. By simply changing the Lewis acid to TMSOTf, we were able to obtain a different tetracyclic compound having additional functionalized 5- and 7-membered rings with complete stereocontrol.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma

Yael Babichev, Leah Kabaroff, Alessandro Datti, David Uehling, Methvin Isaac, Rima Al-awar, Michael Prakesch, Ren X. Sun, Paul C. Boutros, Rosemarie Venier, Brendan C. Dickson, Rebecca A. Gladdy

JOURNAL OF TRANSLATIONAL MEDICINE (2016)

Article Nanoscience & Nanotechnology

Size Reduction of CdSe/ZnS Quantum Dots by a Peptidic Amyloid Supergelator

Md Badruz Zaman, David Bardelang, Michael Prakesch, Donald M. Leek, Jean-Valere Naubron, Gordon Chan, Xiaohua Wu, John A. Ripmeester, Christopher I. Ratcliffe, Kui Yu

ACS APPLIED MATERIALS & INTERFACES (2012)

Article Biochemistry & Molecular Biology

Building skeletally diverse architectures on the Indoline Scaffold: The discovery of a chemical probe of focal adhesion kinase signaling networks

Michael Prakesch, Krikor Bijian, Valerie Campagna-Slater, Sophie Quevillon, Reni Joseph, Chang-Qing Wei, Esther Sesmilo, Ayub Reayi, Rajamohan R. Poondra, Michael L. Barnes, Donald M. Leek, Bin Xu, Caroline Lougheed, Matthieu Schapira, Moulay Alaoui-Jamali, Prabhat Arya

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Article Oncology

Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death

Douglas J. Mahoney, Charles Lefebvre, Kristina Allan, Jan Brun, Cina A. Sanaei, Stephen Baird, Nelson Pearce, Susanna Groenberg, Brian Wilson, Mikael Prakesh, Ahmed Aman, Methvin Isaac, Ahmed Mamai, David Uehling, Rima Al-Awar, Theresa Falls, Tommy Alain, David F. Stojdl

CANCER CELL (2011)

Article Oncology

Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells

Natalie Grinshtein, Alessandro Datti, Mayumi Fujitani, David Uehling, Michael Prakesch, Methvin Isaac, Meredith S. Irwin, Jeffrey L. Wrana, Rima Al-awar, David R. Kaplan

CANCER RESEARCH (2011)

Article Biochemical Research Methods

Use of Kinase Inhibitors to Correct ΔF508-CFTR Function

Agata M. Trzcinska-Daneluti, Leo Nguyen, Chong Jiang, Christopher Fladd, David Uehling, Michael Prakesch, Rima Al-awar, Daniela Rotin

MOLECULAR & CELLULAR PROTEOMICS (2012)

Article Chemistry, Organic

One-pot construction of isoindolo[2,1-a]quinoline system

Shahriar Khadem, Konstantin A. Udachin, Gary D. Enright, Michael Prakesch, Prabhat Arya

TETRAHEDRON LETTERS (2009)

Article Multidisciplinary Sciences

Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors

Mario Sanches, Nicole M. Duffy, Manisha Talukdar, Nero Thevakumaran, David Chiovitti, Marella D. Canny, Kenneth Lee, Igor Kurinov, David Uehling, Rima Al-awar, Gennadiy Poda, Michael Prakesch, Brian Wilson, Victor Tam, Colleen Schweitzer, Andras Toro, Julie L. Lucas, Danka Vuga, Lynn Lehmann, Daniel Durocher, Qingping Zeng, John B. Patterson, Frank Sicheri

NATURE COMMUNICATIONS (2014)

Article Biochemistry & Molecular Biology

A drug discovery platform to identify compounds that inhibit EGFR triple mutants

Punit Saraon, Jamie Snider, Yannis Kalaidzidis, Leanne E. Wybenga-Groot, Konstantin Weiss, Ankit Rai, Nikolina Radulovich, Luka Drecun, Nika Vuckovic, Adriana Vucetic, Victoria Wong, Brigitte Theriault, Nhu-An Pham, Jin H. Park, Alessandro Datti, Jenny Wang, Shivanthy Pathmanathan, Farzaneh Aboualizadeh, Anna Lyakisheva, Zhong Yao, Yuhui Wang, Babu Joseph, Ahmed Aman, Michael F. Moran, Michael Prakesch, Gennady Poda, Richard Marcellus, David Uehling, Miroslav Samarzija, Marko Jakopovic, Ming-Sound Tsao, Frances A. Shepherd, Adrian Sacher, Natasha Leighl, Anna Akhmanova, Rima Al-awar, Marino Zerial, Igor Stagljar

NATURE CHEMICAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Sorafenib as an Inhibitor of RUVBL2

Nardin Nano, Francisca Ugwu, Thiago Seraphim, Tangzhi Li, Gina Azer, Methvin Isaac, Michael Prakesch, Leandro R. S. Barbosa, Carlos H. Ramos, Alessandro Datti, Walid A. Houry

BIOMOLECULES (2020)

Article Biochemistry & Molecular Biology

Functional characterization of a PROTAC directed against BRAF mutant V600E

Ganna Posternak, Xiaojing Tang, Pierre Maisonneuve, Ting Jin, Hugo Lavoie, Salima Daou, Stephen Orlicky, Theo Goullet de Rugy, Lauren Caldwell, Kin Chan, Ahmed Aman, Michael Prakesch, Gennady Poda, Pavel Mader, Cassandra Wong, Stefan Maier, Julia Kitaygorodsky, Brett Larsen, Karen Colwill, Zhe Yin, Derek F. Ceccarelli, Robert A. Batey, Mikko Taipale, Igor Kurinov, David Uehling, Jeff Wrana, Daniel Durocher, Anne-Claude Gingras, Rima Al-Awar, Marc Therrien, Frank Sicheri

NATURE CHEMICAL BIOLOGY (2020)

Article Chemistry, Medicinal

Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma

David E. Uehling, Babu Joseph, Kim Chan Chung, Andrew X. Zhang, Spencer Ler, Michael A. Prakesch, Gennady Poda, Julie Grouleff, Ahmed Aman, Taira Kiyota, Chungyee Leung-Hagesteijn, John David Konda, Richard Marcellus, Carly Griffin, Ratheesh Subramaniam, Ayome Abibi, Craig A. Strathdee, Methvin B. Isaac, Rima Al-Awar, Rodger E. Tiedemann

Summary: The study reveals that targeting GRK6 with small molecule inhibitors is a promising therapeutic approach for multiple myeloma, and identifies a potential novel compound, 18, with potent efficacy.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Correction Chemistry, Medicinal

Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma (vol 64, pg 11129, 2021)

David E. Uehling, Babu Joseph, Kim Chan Chung, Andrew X. Zhang, Spencer Ler, Michael A. Prakesch, Gennady Poda, Julie Grouleff, Ahmed Aman, Taira Kiyota, Chungyee Leung-Hagesteijn, John David Konda, Richard Marcellus, Carly Griffin, Ratheesh Subramaniam, Ayome Abibi, Craig A. Strathdee, Methvin B. Isaac, Rima Al-Awar, Rodger E. Tiedemann

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells

Punit Saraon, Jamie Snider, Wiebke Schormann, Ankit Rai, Nikolina Radulovich, Maria Sanchez-Osuna, Jasmin Coulombe-Huntington, Caroline Huard, Mohammed Mohammed, Evelyne Lima-Fernandes, Brigitte Theriault, Levon Halabelian, Manuel Chan, Dhananjay Joshi, Luka Drecun, Zhong Yao, Shivanthy Pathmanathan, Victoria Wong, Anna Lyakisheva, Farzaneh Aboualizadeh, Li Niu, Fengling Li, Taira Kiyota, Ratheesh Subramanian, Babu Joseph, Ahmed Aman, Michael Prakesch, Methvin Isaac, Ahmed Mamai, Gennady Poda, Masoud Vedadi, Richard Marcellus, David Uehling, Natasha Leighl, Adrian Sacher, Miroslav Samarzija, Marko Jakopovic, Cheryl Arrowsmith, Mike Tyers, Ming-Sound Tsao, David Andrews, Rima Al-awar, Igor Stagljar

Summary: The small molecule EM166 was identified to inhibit mutant EGFR signalling and growth in NSCLC cells via a novel mechanism. EM166 affects the expression and signalling of certain proteins, alters subcellular localization, and modulates the ER stress response pathway in mutant EGFR lung cancer cells.

JOURNAL OF MOLECULAR BIOLOGY (2021)

No Data Available